Unknown

Dataset Information

0

Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.

ABSTRACT: Emerging reports of SARS-CoV-2 breakthrough infections entail methodical genomic surveillance for determining the efficacy of vaccines. This study elaborates genomic analysis of isolates from breakthrough infections following vaccination with AZD1222/Covishield and BBV152/Covaxin. Variants of concern B.1.617.2 and B.1.1.7 responsible for cases surge in April-May 2021 in Delhi, were the predominant lineages among breakthrough infections.

SUBMITTER: Singh UB 

PROVIDER: S-EPMC8662202 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Emerging reports of SARS-CoV-2 breakthrough infections entail methodical genomic surveillance for determining the efficacy of vaccines. This study elaborates genomic analysis of isolates from breakthrough infections following vaccination with AZD1222/Covishield and BBV152/Covaxin. Variants of concern B.1.617.2 and B.1.1.7 responsible for cases surge in April-May 2021 in Delhi, were the predominant lineages among breakthrough infections. ...[more]

Similar Datasets

Unknown Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
| S-EPMC8117968 | biostudies-literature
Unknown Emerging Vaccine-Breakthrough SARS-CoV-2 Variants.
| S-EPMC8848511 | biostudies-literature
Unknown Emerging vaccine-breakthrough SARS-CoV-2 variants.
| S-EPMC8437313 | biostudies-literature
Unknown Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.
| S-EPMC8143909 | biostudies-literature
Unknown Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern.
| S-EPMC10073596 | biostudies-literature
Unknown Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people with HIV.
| S-EPMC10089930 | biostudies-literature
Unknown Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants.
| S-EPMC8930394 | biostudies-literature
Unknown Vaccine Breakthrough Infections by SARS-CoV-2 Variants after ChAdOx1 nCoV-19 Vaccination in Healthcare Workers.
| S-EPMC8778656 | biostudies-literature
Unknown Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections.
| S-EPMC8795418 | biostudies-literature
Unknown Investigating SARS-CoV-2 breakthrough infections per variant and vaccine type.
| S-EPMC9729533 | biostudies-literature